formaldehyde has been researched along with naltrexone in 49 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (4.08) | 18.7374 |
1990's | 14 (28.57) | 18.2507 |
2000's | 21 (42.86) | 29.6817 |
2010's | 11 (22.45) | 24.3611 |
2020's | 1 (2.04) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Melzack, R; Plamondon, H; Vaccarino, AL | 1 |
Helmstetter, FJ; Landeira-Fernandez, J | 1 |
Abbott, FV | 1 |
Calcagnetti, DJ; Fanselow, MS; Helmstetter, FJ | 1 |
Fanselow, MS | 1 |
Krause, JE; McCarson, KE | 1 |
Hitosugi, H; Kamei, J; Kasuya, Y | 1 |
Blommaert, A; Fournié-Zaluski, MC; Noble, F; Roques, BP | 1 |
Hitosugi, H; Kamei, J; Kasuya, Y; Misawa, M; Nagase, H | 1 |
Cowan, A; Hunter, JC; Kovelowski, CJ; Lai, J; Malan, TP; Ossipov, MH; Porreca, F; Wheeler-Aceto, H | 1 |
Altier, N; Stewart, J | 1 |
Grouhel, A; Wettstein, JG | 1 |
Hitosugi, H; Kamei, J; Kashiwazaki, T; Nagase, H | 1 |
Hao, S; Ogawa, H | 1 |
Kishimoto, Y; Misawa, M; Nagase, H; Suzuki, T; Takeda, F | 1 |
Hitosugi, H; Kamei, J; Kashiwazaki, T; Nagase, H; Taki, K | 1 |
Hao, S; Iwasaki, H; Takahata, O | 1 |
Arai, K; Furuta, S; Hayashi, T; Katsuyama, S; Kisara, K; Miyazaki, S; Onodera, K; Sakurada, S; Sato, T; Yonezawa, A | 1 |
Fink, DJ; Glorioso, JC; Goins, WF; Goss, JR; Mata, M; Wu, HH | 1 |
Lutz, EA; Shannon, HE | 1 |
Hung, KC; Mizoguchi, H; Nagase, H; Tseng, LF; Wu, HE | 1 |
Hao, S; Iwasaki, H; Mamiya, K; Takahata, O | 1 |
Borghi, V; Ilona, O; Labuz, D; Maj, M; Pavone, F; Przewlocka, B | 1 |
Blisnick, T; Desor, D; Dugave, C; Hermitte, V; Messaoudi, M; Rigault, AG; Rougeon, F; Rougeot, C | 1 |
Choi, SS; Han, EJ; Han, KJ; Lee, HK; Suh, HW | 1 |
Brandão, ML; de Luca, MC; Landeira-Fernandez, J; Motta, VA | 1 |
Ise, Y; Kishimoto, Y; Misawa, K; Narita, M; Suzuki, T; Yajima, Y | 1 |
Clemente, JT; Gear, RW; Parada, CA; Tambeli, CH; Veiga, MC | 1 |
Arthuri, MT; de Arruda Veiga, MC; Gameiro, GH; Tambeli, CH | 1 |
Angers, P; Dalbó, S; Jürgensen, S; Ribeiro-do-Valle, RM; Santos, AR | 1 |
Lane, DA; Morgan, MM; Patel, PA | 1 |
Chugh, C; Jain, H; Mediratta, PK; Rathi, N; Reeta, Kh; Sharma, KK | 1 |
Kang, HW; Kim, JH; Kim, MS; Koo, S; Lee, SJ; Lyu, YS; Park, BR; Sohn, IC; Song, JH | 1 |
Campisi, G; De Caro, V; Florena, AM; Giandalia, G; Giannola, LI; Siragusa, MG; Tripodo, C | 1 |
Hamabe, W; Mashida, E; Nagae, R; Tokuyama, S | 1 |
Ambriz-Tututi, M; Araiza-Saldaña, CI; Arreola-Espino, R; Caram-Salas, NL; Granados-Soto, V; Mixcoatl-Zecuatl, T; Rocha-González, HI; Urquiza-Marín, H | 1 |
Cowan, A; Dun, NJ; Inan, S | 1 |
Botelho, AP; de Arruda Veiga, MC; Gameiro, GH; Marcondes, FK; Tuma, CE | 1 |
Chicre-Alcântara, TC; Clemente-Napimoga, JT; Fischer, L; Melo, V; Parada, CA; Tambeli, CH; Torres-Chávez, KE | 1 |
Gonzalez, C; Miranda, HF; Noriega, V; Prieto, JC; Zegpi, C | 1 |
Ambriz-Tututi, M; Drucker-Colín, R; Sánchez-González, V | 1 |
Lee, H | 1 |
Cervantes-Durán, C; Espinosa de los Monteros-Zuñiga, A; Godínez-Chaparro, B; Izquierdo, T; Lozada, MC | 1 |
Nagase, H; Oka, J; Saitoh, A; Sugiyama, A; Yamada, M | 1 |
Carlezon, WA; Cheng, K; Leitl, MD; Negus, SS; Potter, DN; Rice, KC | 1 |
Fanton, LE; Fischer, L; Macedo, CG; Tambeli, CH | 1 |
Katsuyama, S; Komatsu, T; Kubota, A; Morinaga, O; Ogawa, K; Okamura, T; Sakurada, C; Sakurada, T; Tabata, K; Takano, F; Tsuzuki, M | 1 |
Capim, SL; Côrtes, WDS; Gonçalves, GM; Laureano-Melo, R; Marinho, BG; Oliveira, PA; Vasconcellos, MLAA | 1 |
49 other study(ies) available for formaldehyde and naltrexone
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Analgesic and aversive effects of naloxone in BALB/c mice.
Topics: Analgesia; Animals; Choice Behavior; Dose-Response Relationship, Drug; Formaldehyde; Mice; Mice, Inbred BALB C; Naloxone; Naltrexone; Pain | 1992 |
Conditional hypoalgesia is attenuated by naltrexone applied to the periaqueductal gray.
Topics: Animals; Behavior, Animal; Conditioning, Operant; Electroshock; Female; Formaldehyde; Microinjections; Naltrexone; Pain; Periaqueductal Gray; Rats; Receptors, Opioid | 1990 |
beta-Funaltrexamine antagonizes the analgesic effects of mu and kappa agonists in the formalin test.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Dose-Response Relationship, Drug; Ethylketocyclazocine; Formaldehyde; Male; Morphine; Naltrexone; Narcotic Antagonists; Pain; Pyrrolidines; Rats; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Urination | 1990 |
Role of mu and kappa opioid receptors in conditional fear-induced analgesia: the antagonistic actions of nor-binaltorphimine and the cyclic somatostatin octapeptide, Cys2Tyr3Orn5Pen7-amide.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Behavior, Animal; Fear; Female; Formaldehyde; Naltrexone; Pain; Pyrrolidines; Rats; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Somatostatin | 1989 |
Conditioned fear-induced opiate analgesia: a competing motivational state theory of stress analgesia.
Topics: Analgesia; Animals; Avoidance Learning; Behavior, Animal; Conditioning, Classical; Endorphins; Fear; Formaldehyde; Models, Biological; Motor Activity; Naloxone; Naltrexone; Nociceptors; Sensory Thresholds; Shock; Stress, Physiological | 1986 |
The formalin-induced expression of tachykinin peptide and neurokinin receptor messenger RNAs in rat sensory ganglia and spinal cord is modulated by opiate preadministration.
Topics: Animals; Formaldehyde; Ganglia, Spinal; Gene Expression Regulation; Male; Morphine; Naltrexone; Neurokinin B; Pain; Premedication; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Receptors, Neurokinin-3; RNA, Messenger; Spinal Cord; Substance P; Time Factors | 1995 |
Formalin-induced nociceptive responses in diabetic mice.
Topics: Analgesics; Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Formaldehyde; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Nociceptors; Receptors, Opioid, delta; Substance P | 1993 |
A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test.
Topics: Analgesics; Animals; Disulfides; Enkephalins; Formaldehyde; Indoles; Male; Meglumine; Mice; Morphine; Naloxone; Naltrexone; Pain Measurement; Phenylalanine; Receptors, Cholecystokinin; Receptors, Opioid, delta; Receptors, Opioid, mu | 1995 |
Delta-opiod receptor-mediated forced swimming stress-induced antinociception in the formalin test.
Topics: Animals; Formaldehyde; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Nociceptors; Pain Measurement; Receptors, Opioid, delta; Stress, Psychological; Swimming | 1993 |
Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin: demonstration of an opioid kappa and delta inhibitory tone.
Topics: Animals; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Formaldehyde; Immune Sera; Male; Naloxone; Naltrexone; Narcotic Antagonists; Opioid Peptides; Pain; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa | 1996 |
Opioid receptors in the ventral tegmental area contribute to stress-induced analgesia in the formalin test for tonic pain.
Topics: Analgesia; Animals; Electroshock; Formaldehyde; Male; Naltrexone; Narcotic Antagonists; Pain Measurement; Rats; Rats, Wistar; Receptors, Opioid; Stress, Psychological; Ventral Tegmental Area | 1996 |
Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Formaldehyde; Male; Mice; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Pain Measurement; Pyrroles; Pyrrolidines; Receptors, Opioid, kappa; Receptors, Opioid, mu; Thiophenes | 1996 |
The role of spinal delta1-opioid receptors in inhibiting the formalin-induced nociceptive response in diabetic mice.
Topics: Analgesics; Animals; Benzylidene Compounds; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Formaldehyde; Injections, Intraventricular; Injections, Spinal; Injections, Subcutaneous; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Pain Measurement; Receptors, Opioid, delta; Spinal Cord | 1997 |
Naltrexone, but not atropine or yohimbine, antagonizes suppression of formalin-induced spinal sensitization by intrathecal nociceptin.
Topics: Animals; Atropine; Depression, Chemical; Formaldehyde; Injections, Spinal; Injections, Subcutaneous; Male; Naltrexone; Narcotic Antagonists; Nociceptin; Nociceptors; Opioid Peptides; Pain Measurement; Parasympatholytics; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Spine; Sympatholytics; Yohimbine | 1998 |
Role of the kappa-opioid system in the attenuation of the morphine-induced place preference under chronic pain.
Topics: Animals; Chronic Disease; Conditioning, Psychological; Formaldehyde; Hindlimb; Inflammation; Male; Morphine; Naltrexone; Pain; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa; Reward; Time Factors | 1999 |
Algogenic mediator-induced nociceptive response in diabetic mice.
Topics: Animals; Benzylidene Compounds; Bradykinin; Diabetes Mellitus, Experimental; Dinoprost; Dose-Response Relationship, Drug; Formaldehyde; Injections, Subcutaneous; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Pain; Receptors, Opioid, delta; Somatostatin | 1999 |
Electroacupuncture potentiates the antinociceptive effect of intrathecal endomorphin-1 in the rat formalin test.
Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Electroacupuncture; Formaldehyde; Injections, Spinal; Male; Naltrexone; Nociceptors; Oligopeptides; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Opioid | 2000 |
Differential involvement of opioid receptors in stress-induced antinociception caused by repeated exposure to forced walking stress in mice.
Topics: Animals; Formaldehyde; Male; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Pain Measurement; Receptors, Opioid; Stress, Physiological; Walking | 2000 |
Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion.
Topics: Analgesia; Animals; Enkephalins; Formaldehyde; Ganglia, Spinal; Genetic Therapy; Genetic Vectors; Humans; Male; Naltrexone; Pain Measurement; Protein Precursors; Rats; Rats, Wistar; Simplexvirus; Transfection | 2001 |
Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats.
Topics: Analgesics, Opioid; Animals; Antidiarrheals; Cisterna Magna; Dose-Response Relationship, Drug; Formaldehyde; Injections; Injections, Subcutaneous; Loperamide; Male; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2002 |
Roles of endogenous opioid peptides in modulation of nocifensive response to formalin.
Topics: Animals; Antibodies, Blocking; Dynorphins; Endorphins; Enkephalins; Formaldehyde; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Pain Measurement; Receptors, Opioid; Somatostatin; Spinal Cord | 2002 |
Sevoflurane suppresses noxious stimulus-evoked expression of Fos-like immunoreactivity in the rat spinal cord via activation of endogenous opioid systems.
Topics: Analgesics; Anesthetics, Inhalation; Animals; Formaldehyde; Male; Methyl Ethers; Naloxone; Naltrexone; Narcotic Antagonists; Opioid Peptides; Pain Measurement; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Sevoflurane; Spinal Cord | 2002 |
Formalin-induced pain and mu-opioid receptor density in brain and spinal cord are modulated by A1 and A2a adenosine agonists in mice.
Topics: Adenosine; Animals; Autoradiography; Central Nervous System; Fixatives; Formaldehyde; Male; Mice; Motor Activity; Naltrexone; Narcotic Antagonists; Pain; Periaqueductal Gray; Phenethylamines; Purinergic P1 Receptor Agonists; Receptor, Adenosine A2A; Receptors, Opioid, mu; Receptors, Purinergic P1; Spinal Cord; Thalamus | 2002 |
Sialorphin, a natural inhibitor of rat membrane-bound neutral endopeptidase that displays analgesic activity.
Topics: Amino Acid Sequence; Analgesics; Animals; Enkephalin, Methionine; Formaldehyde; Glycopeptides; Kidney; Leucine; Male; Membrane Proteins; Molecular Sequence Data; Naltrexone; Neprilysin; Pain; Pain Measurement; Prostate; Protease Inhibitors; Protein Precursors; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, mu; Salivary Proteins and Peptides; Spinal Cord; Submandibular Gland; Substance P; Thiorphan; Wounds and Injuries | 2003 |
Possible antinociceptive mechanisms of opioid receptor antagonists in the mouse formalin test.
Topics: 5,7-Dihydroxytryptamine; Animals; Behavior, Animal; Benzylamines; Formaldehyde; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Pain Measurement; Receptors, Opioid, delta; Receptors, Opioid, mu | 2003 |
Antinociception induced by stimulation of ventrolateral periaqueductal gray at the freezing threshold is regulated by opioid and 5-HT2A receptors as assessed by the tail-flick and formalin tests.
Topics: Algorithms; Animals; Electric Stimulation; Formaldehyde; Ketanserin; Male; Microinjections; Naltrexone; Narcotic Antagonists; Pain; Pain Measurement; Periaqueductal Gray; Rats; Rats, Wistar; Reaction Time; Receptor, Serotonin, 5-HT2A; Receptors, Opioid; Serotonin Antagonists; Stereotaxic Techniques | 2003 |
Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state.
Topics: Animals; Brain Chemistry; Conditioning, Operant; Dopamine; Dynorphins; Edema; Foot; Formaldehyde; Inflammation; Limbic System; Male; Microdialysis; Microinjections; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reward | 2005 |
Sexual dimorphism in the antinociception mediated by kappa opioid receptors in the rat temporomandibular joint.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Dose-Response Relationship, Drug; Estrous Cycle; Female; Formaldehyde; Male; Naltrexone; Pain Measurement; Rats; Rats, Wistar; Receptors, Opioid, kappa; Sex Characteristics; Temporomandibular Joint | 2004 |
Peripheral effect of a kappa opioid receptor antagonist on nociception evoked by formalin injected in TMJ of pregnant rats.
Topics: Animals; Female; Formaldehyde; Naltrexone; Pain; Pregnancy; Pregnancy, Animal; Rats; Rats, Wistar; Receptors, Opioid, kappa; Temporomandibular Joint | 2005 |
Involvement of 5-HT2 receptors in the antinociceptive effect of Uncaria tomentosa.
Topics: Acetic Acid; Analgesics; Animals; Arginine; Atropine; Behavior, Animal; Capsaicin; Cat's Claw; Dose-Response Relationship, Drug; Formaldehyde; Ketanserin; Male; Mice; Motor Activity; Naltrexone; Pain; Pain Measurement; Phytotherapy; Plant Preparations; Prazosin; Receptors, Serotonin, 5-HT2; Reserpine; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Yohimbine | 2005 |
Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats.
Topics: Analgesics; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Formaldehyde; GABA Agonists; GABA-A Receptor Agonists; Male; Medulla Oblongata; Morphine; Muscimol; Naltrexone; Narcotic Antagonists; Neurons; Pain Measurement; Periaqueductal Gray; Rats; Rats, Sprague-Dawley | 2005 |
Role of kappa- and delta-opioid receptors in the antinociceptive effect of oxytocin in formalin-induced pain response in mice.
Topics: Analgesics; Animals; Behavior; Calcium Channel Blockers; Dose-Response Relationship, Drug; Formaldehyde; Mice; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Nimodipine; Oxytocin; Pain; Random Allocation; Receptors, Opioid, delta; Receptors, Opioid, kappa | 2006 |
Antinociception of heterotopic electro-acupuncture mediated by the dorsolateral funiculus.
Topics: Acupuncture Points; Animals; Behavior, Animal; Electroacupuncture; Formaldehyde; Injections, Subcutaneous; Male; Naltrexone; Narcotic Antagonists; Neurons; Pain; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Spinal Cord | 2007 |
Release of naltrexone on buccal mucosa: permeation studies, histological aspects and matrix system design.
Topics: Administration, Buccal; Animals; Chemistry, Pharmaceutical; Drug Administration Routes; Drug Delivery Systems; Formaldehyde; Iontophoresis; Kinetics; Mouth Mucosa; Naltrexone; Narcotic Antagonists; Spectrophotometry, Infrared; Swine; Tablets; Time Factors | 2007 |
Involvement of kappa opioid receptors in formalin-induced inhibition of analgesic tolerance to morphine in mice.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Chronic Disease; Drug Tolerance; Formaldehyde; Male; Mice; Morphine; Naltrexone; Oligonucleotides, Antisense; Pain; Pain Measurement; Pain Threshold; Receptors, Opioid, delta; Receptors, Opioid, kappa; Tail | 2007 |
Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats.
Topics: Analgesics; Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Female; Formaldehyde; Guanidines; Indoles; Melatonin; Naltrexone; Narcotic Antagonists; Pain; Pain Measurement; Pain Threshold; Physical Stimulation; Postural Balance; Rats; Rats, Wistar; Receptor, Melatonin, MT2 | 2007 |
Inhibitory effect of lidocaine on pain and itch using formalin-induced nociception and 5'-guanidinonaltrindole-induced scratching models in mice: behavioral and neuroanatomical evidence.
Topics: Animals; Behavior, Animal; Formaldehyde; Gene Expression Regulation; Guanidines; Lidocaine; Male; Mice; Morphinans; Naltrexone; Neurons; Pain; Proto-Oncogene Proteins c-fos; Pruritus; Receptors, Opioid, kappa | 2009 |
The effects of acute restraint stress on nociceptive responses evoked by the injection of formalin into the temporomandibular joint of female rats.
Topics: Acute Disease; Animals; Behavior, Animal; Estrus; Female; Formaldehyde; Naltrexone; Narcotic Antagonists; Nociceptors; Pain; Pain Measurement; Proestrus; Rats; Rats, Wistar; Receptors, Opioid; Restraint, Physical; Stress, Physiological; Temporomandibular Joint; Temporomandibular Joint Disorders | 2010 |
Local kappa opioid receptor activation decreases temporomandibular joint inflammation.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Movement; Dose-Response Relationship, Drug; Formaldehyde; Inflammation; Male; Naltrexone; Neutrophil Infiltration; Neutrophils; Rats; Rats, Wistar; Receptors, Opioid, kappa; Temporomandibular Joint | 2012 |
Synergism between dexketoprofen and meloxicam in an orofacial formalin test was not modified by opioid antagonists.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Facial Pain; Formaldehyde; Ketoprofen; Male; Meloxicam; Mice; Naltrexone; Narcotic Antagonists; Stereoisomerism; Thiazines; Thiazoles | 2011 |
Chromaffin cell transplant in spinal cord reduces secondary allodynia induced by formalin in the rat. Role of opioid receptors and α₂-adrenoceptors.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Cell Survival; Chromaffin Cells; Female; Formaldehyde; Hyperalgesia; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, Opioid; Spinal Cord; Yohimbine | 2011 |
Effects of co-administration of intrathecal nociceptin/orphanin FQ and opioid antagonists on formalin-induced pain in rats.
Topics: Analgesics; Animals; Formaldehyde; Injections, Spinal; Male; Naltrexone; Narcotic Antagonists; Nociceptin; Opioid Peptides; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Opioid | 2013 |
Mechanisms underlying the antinociceptive effect of mangiferin in the formalin test.
Topics: Analgesics; Animals; Capsaicin; Formaldehyde; Glyburide; Male; Naloxone; Naltrexone; NG-Nitroarginine Methyl Ester; Nociception; Quinoxalines; Rats; Rats, Wistar; Serotonin; Xanthones | 2013 |
DOR(2)-selective but not DOR(1)-selective antagonist abolishes anxiolytic-like effects of the δ opioid receptor agonist KNT-127.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Benzylidene Compounds; Exploratory Behavior; Formaldehyde; Male; Maze Learning; Morphinans; Naltrexone; Narcotic Antagonists; Neuropsychological Tests; Nociception; Rats; Rats, Wistar; Receptors, Opioid, delta | 2014 |
Sustained pain-related depression of behavior: effects of intraplantar formalin and complete freund's adjuvant on intracranial self-stimulation (ICSS) and endogenous kappa opioid biomarkers in rats.
Topics: Analgesics, Opioid; Animals; Body Weight; Conditioning, Operant; Disease Models, Animal; Formaldehyde; Freund's Adjuvant; Hyperalgesia; Inhibition, Psychological; Male; Morphine; Naltrexone; Narcotic Antagonists; Pain; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Self Stimulation | 2014 |
Coactivation of μ- and κ-Opioid Receptors May Mediate the Protective Effect of Testosterone on the Development of Temporomandibular Joint Nociception in Male Rats.
Topics: Animals; Brain Stem; Facial Pain; Formaldehyde; Male; Naloxone; Naltrexone; Narcotic Antagonists; Nociception; Nociceptive Pain; Orchiectomy; Rats; Rats, Wistar; Receptors, Opioid, kappa; Receptors, Opioid, mu; Somatostatin; Temporomandibular Joint; Temporomandibular Joint Disorders; Testosterone; Trigeminal Caudal Nucleus | 2016 |
Possible involvement of the μ opioid receptor in the antinociception induced by sinomenine on formalin-induced nociceptive behavior in mice.
Topics: Administration, Oral; Analgesics; Animals; Dose-Response Relationship, Drug; Formaldehyde; Male; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Morphinans; Naloxone; Naltrexone; Nociception; Receptors, Opioid, mu; Spinal Cord | 2019 |
Pharmacological evaluation underlying the antinociceptive activity of two new hybrids NSAIDs tetrahydropyran derivatives.
Topics: Adenosine Triphosphate; Analgesics; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclic GMP; Cyclooxygenase Inhibitors; Dizocilpine Maleate; Formaldehyde; Glyburide; Humans; Male; Mice; Naloxone; Naltrexone; NG-Nitroarginine Methyl Ester; Pain; Pain Measurement; Potassium Channels; Prostaglandin-Endoperoxide Synthases; Receptors, N-Methyl-D-Aspartate; Signal Transduction | 2020 |